Withdrawal of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Elicits Oxidative Stress and Induces Endothelial Dysfunction in Mice
- 26 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 91 (2), 173-179
- https://doi.org/10.1161/01.res.0000028004.76218.b8
Abstract
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) improve endothelial function. We determined whether withdrawal of statin therapy affects endothelium-dependent relaxation in mic...Keywords
This publication has 24 references indexed in Scilit:
- Vascular endothelial growth factor induces manganese‐superoxide dismutase expression in endothelial cells by a Racl‐regulated NADPH oxidase‐dependent mechanismThe FASEB Journal, 2001
- Mechanism of NADPH Oxidase Activation by the Rac/Rho-GDI ComplexBiochemistry, 2001
- Statin therapy: where are we? where do we go next?The American Journal of Cardiology, 2001
- Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular diseaseCardiovascular Research, 2001
- Manganese superoxide dismutase in diseaseFree Radical Research, 2001
- Direct Vascular Effects of HMG-CoA Reductase InhibitorsTrends in Cardiovascular Medicine, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Protective roles of cytokines against radiation: Induction of mitochondrial MnSODBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- Tolerance, rebound, and time-zero effect of nitrate therapyThe American Journal of Cardiology, 1992
- Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1Nature, 1991